Company's annual revenue growth of 46.56% outperformed its 3 year CAGR of 30.82%. (Source: Standalone Financials)
Narendra Investments - Eiko Lifesciences Share Price
Narendra Investments - ...
Narendra Investments share price insights
Company has spent less than 1% of its operating revenues towards interest expenses and 0.79% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)
Eiko Lifesciences Ltd. share price moved up by 4.28% from its previous close of Rs 55.33. Eiko Lifesciences Ltd. stock last traded price is 57.70
Share Price Value Today/Current/Last 57.70 Previous Day 55.33
Key Metrics
PE Ratio (x) | 78.78 | ||||||||||
EPS - TTM (₹) | 0.73 | ||||||||||
MCap (₹ Cr.) | 80.22 | ||||||||||
Sectoral MCap Rank | 167 | ||||||||||
PB Ratio (x) | 68.88 | ||||||||||
Div Yield (%) | 0.00 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
Beta Beta
| 0.19 | ||||||||||
VWAP (₹) | 57.61 | ||||||||||
52W H/L (₹) |
Narendra Investments Share Price Returns
1 Day | 4.28% |
1 Week | -1.52% |
1 Month | -7.23% |
3 Months | 15.17% |
1 Year | -3.54% |
3 Years | N.A. |
5 Years | N.A. |
Narendra Investments News & Analysis
Narendra Investments Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
Narendra Investments Financials
Income (P&L)
Balance Sheet
Cash Flow
Ratios
Insights
Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 46.56% outperformed its 3 year CAGR of 30.82%. (Source: Standalone Financials)Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 0.79% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)
No reported Profit & Loss Statement are available.
No reported Balance Sheet are available.
No reported Cash Flow Statement are available.
No reported Financial Ratios are available.
Narendra Investments Peer Comparison
Narendra Investments Stock Performance
Ratio Performance
Choose from Peers
Choose from Stocks
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...- See All Parameters
MF Ownership
MF Ownership details are not available.
Corporate Actions
Narendra Investments Board Meeting/AGM
Narendra Investments Dividends
- Others
Meeting Date Announced on Purpose Details Aug 13, 2024 Aug 05, 2024 Board Meeting Quarterly Results May 13, 2024 May 06, 2024 Board Meeting Audited Results Feb 08, 2024 Feb 01, 2024 Board Meeting Quarterly Results Dec 14, 2023 Dec 11, 2023 Board Meeting Others Nov 08, 2023 Oct 30, 2023 Board Meeting Quarterly Results Type Dividend Dividend per Share Ex-Dividend Date Announced on Final 2% 0.25 Sep 20, 2017 Aug 14, 2017 All Types Ex-Date Record Date Announced on Details Rights Jul 07, 2023 Jul 07, 2023 Jan 31, 2023 Rights ratio: 2 share for every 3 held at a price of Rs 45.0
About Narendra Investments
Eiko Lifesciences Ltd., incorporated in the year 1977, is a Small Cap company (having a market cap of Rs 76.37 Crore) operating in Financial Services sector. Eiko Lifesciences Ltd. key Products/Revenue Segments include Speciality Chemicals and Duty Drawback for the year ending 31-Mar-2023. Show More
Executives
Auditors
- LR
Laxmikant Ramprasad Kabra
Chairman & Non-Exe.DirectorLRLaxmikant Ramprasad Kabra
Chairman & Non-Exe.DirectorLRLaxmikant Ramprasad Kabra
Chairman & Non-Exe.DirectorLRLaxmikant Ramprasad Kabra
Chairman & Non-Exe.DirectorShow More - Thanawala & Co.Shah & Kathariya
Industry
Key Indices Listed on
-
Address
604, Centrum,Opp. Raila Devi Lake,Near Satkar Grande Hotel,Thane, Maharashtra - 400604
More Details
Trending in Markets
Narendra Investments Quick Links
Equity Quick Links
More from Markets
IPOStock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.